Tracing HIV-1 strains that imprint broadly neutralizing antibody responses.

Kouyos, Roger D; Rusert, Peter; Kadelka, Claus; Huber, Michael; Marzel, Alex; Ebner, Hanna; Schanz, Merle; Liechti, Thomas; Friedrich, Nikolas; Braun, Dominique L; Scherrer, Alexandra U; Weber, Jacqueline; Uhr, Therese; Baumann, Nicolas S; Leemann, Christine; Kuster, Herbert; Chave, Jean-Philippe; Cavassini, Matthias; Bernasconi, Enos; Hoffmann, Matthias; ... (2018). Tracing HIV-1 strains that imprint broadly neutralizing antibody responses. Nature, 561(7723), pp. 406-410. Macmillan Journals Ltd. 10.1038/s41586-018-0517-0

[img] Text
s41586-018-0517-0.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (4MB)

Understanding the determinants of broadly neutralizing antibody (bNAb) evolution is crucial for the development of bNAb-based HIV vaccines. Despite emerging information on cofactors that promote bNAb evolution in natural HIV-1 infections, in which the induction of bNAbs is genuinely rare, information on the impact of the infecting virus strain on determining the breadth and specificity of the antibody responses to HIV-1 is lacking. Here we analyse the influence of viral antigens in shaping antibody responses in humans. We call the ability of a virus strain to induce similar antibody responses across different hosts its antibody-imprinting capacity, which from an evolutionary biology perspective corresponds to the viral heritability of the antibody responses. Analysis of 53 measured parameters of HIV-1-binding and neutralizing antibody responses in a cohort of 303 HIV-1 transmission pairs (individuals who harboured highly related HIV-1 strains and were putative direct transmission partners or members of an HIV-1 transmission chain) revealed that the effect of the infecting virus on the outcome of the bNAb response is moderate in magnitude but highly significant. We introduce the concept of bNAb-imprinting viruses and provide evidence for the existence of such viruses in a systematic screening of our cohort. The bNAb-imprinting capacity can be substantial, as indicated by a transmission pair with highly similar HIV-1 antibody responses and strong bNAb activity. Identification of viruses that have bNAb-imprinting capacities and their characterization may thus provide the potential to develop lead immunogens.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology

UniBE Contributor:

Rauch, Andri

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0028-0836

Publisher:

Macmillan Journals Ltd.

Language:

English

Submitter:

Annelies Luginbühl

Date Deposited:

02 Nov 2018 14:02

Last Modified:

05 Dec 2022 15:18

Publisher DOI:

10.1038/s41586-018-0517-0

PubMed ID:

30202088

BORIS DOI:

10.7892/boris.119985

URI:

https://boris.unibe.ch/id/eprint/119985

Actions (login required)

Edit item Edit item
Provide Feedback